Cytek Biosciences
CTKB
CTKB
88 hedge funds and large institutions have $899M invested in Cytek Biosciences in 2022 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 38 increasing their positions, 19 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
5.98% more ownership
Funds ownership: 39.37% → 45.35% (+6%)
5% more funds holding
Funds holding: 84 → 88 (+4)
Holders
88
Holding in Top 10
4
Calls
$3.24M
Puts
–
Top Buyers
| 1 | +$64.9M | |
| 2 | +$20.8M | |
| 3 | +$19M | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
+$13.2M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$11.8M |
Top Sellers
| 1 | -$12.7M | |
| 2 | -$12.2M | |
| 3 | -$9.84M | |
| 4 |
Millennium Management
New York
|
-$7.27M |
| 5 |
GCM
Glenview Capital Management
New York
|
-$5.37M |